{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:11:25Z","timestamp":1786119085296,"version":"build-2736575974"},"reference-count":46,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1097\/cej.0b013e32811080ce","type":"journal-article","created":{"date-parts":[[2009,3,5]],"date-time":"2009-03-05T09:04:21Z","timestamp":1236243861000},"page":"133-138","source":"Crossref","is-referenced-by-count":60,"title":["From endometrial hyperplasia to endometrial cancer: insight into the biology and possible medical preventive measures"],"prefix":"10.1097","volume":"17","author":[{"given":"Melih C.","family":"Boruban","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kadri","family":"Altundag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gokhan S.","family":"Kilic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Blankstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-9-20210128","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ejogrb.2004.07.002","article-title":"Aromatase inhibitor anastrozole for treating endometrial hyperplasia in obese postmenopausal women","volume":"118","author":"Agorastos","year":"2005","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R2-9-20210128","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/01.cej.0000136717.95465.09","article-title":"P53 codon 72 polymorphism and correlation with ovarian and endometrial cancer in Greek women","volume":"13","author":"Agorastos","year":"2004","journal-title":"Eur J Cancer Prev"},{"key":"R3-9-20210128","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/0090-8258(83)90111-7","article-title":"Two pathogenetic types of endometrial carcinoma","volume":"15","author":"Bokhman","year":"1983","journal-title":"Gynecol Oncol"},{"key":"R4-9-20210128","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0960-0760(01)00131-5","article-title":"Aromatase and COX-2 expression in human breast cancers","volume":"79","author":"Brodie","year":"2001","journal-title":"J Steroid Biochem Mol Biol"},{"key":"R5-9-20210128","first-page":"1831","article-title":"CYP19 (aromatase cytochrome P450) gene expression in human malignant endometrial tumors","volume":"79","author":"Bulun","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"R6-9-20210128","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1677\/jme.0.0250035","article-title":"Estrogen biosynthesis in endometriosis: molecular basis and clinical relevance","volume":"25","author":"Bulun","year":"2000","journal-title":"J Mol Endocrinol"},{"key":"R7-9-20210128","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0029-7844(97)00577-2","article-title":"Risk of endometrial cancer in relation to use of low-dose, unopposed estrogens","volume":"91","author":"Cushing","year":"1998","journal-title":"Obstet Gynecol"},{"key":"R8-9-20210128","doi-asserted-by":"crossref","first-page":"8258","DOI":"10.1158\/1078-0432.CCR-05-1189","article-title":"Identification of a novel estrogen-regulated gene, EIG121, induced by hormone replacement therapy and differentially expressed in type I and type II","volume":"11","author":"Deng","year":"2005","journal-title":"Endometrial Cancer Clin Cancer Res"},{"key":"R9-9-20210128","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1210\/jc.2002-021844","article-title":"Coordinate regulation of the production and signaling of retinoic acid by estrogen in the human endometrium","volume":"88","author":"Deng","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"R10-9-20210128","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1093\/humrep\/dei322","article-title":"On behalf of the ATAC Trialists' Group The ATAC (\u2018Arimidex\u2019, Tamoxifen, Alone or in Combination) adjuvant breast cancer trial: first results of the endometrial sub-protocol following 2 years of treatment","volume":"21","author":"Duffy","year":"2006","journal-title":"Human Reprod"},{"key":"R11-9-20210128","first-page":"231","article-title":"Clinicopathologic review of 118 granulosa and 82 theca cell tumors","volume":"55","author":"Evans","year":"1980","journal-title":"Obstet Gynecol"},{"key":"R12-9-20210128","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/cncr.10736","article-title":"Cyclooxygenase-2 expression in endometrial carcinoma: correlation with clinicopathologic parameters and clinical outcome","volume":"95","author":"Ferrandina","year":"2002","journal-title":"Cancer"},{"key":"R13-9-20210128","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.ygyno.2006.04.004","article-title":"Prospective endometrial assessment of breast cancer patients treated with third generation aromatase inhibitors","volume":"103","author":"Garuti","year":"2006","journal-title":"Gynecol Oncol"},{"key":"R14-9-20210128","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1001\/archinte.1997.00440430091011","article-title":"Low-dose esterified estrogen therapy: effects on bone, plasma estradiol concentrations, endometrium, and lipid levels. Estratab\/Osteoporosis Study Group","volume":"157","author":"Genant","year":"1997","journal-title":"Arch Intern Med"},{"key":"R15-9-20210128","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1158\/1078-0432.CCR-05-0225","article-title":"Anastrozole vs. tamoxifen treatment in postmenopausal women with endocrine-responsive breast cancer and tamoxifen-induced endometrial pathology","volume":"12","author":"Gerber","year":"2006","journal-title":"Clin Cancer Res"},{"key":"R16-9-20210128","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1056\/NEJM199305063281805","article-title":"Treatment of colonic and rectal adenomas with sulindac infamilial adenomatous polyposis","volume":"328","author":"Giardiello","year":"1993","journal-title":"N Eng J Med"},{"key":"R17-9-20210128","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1210\/jcem-36-2-207","article-title":"Source of estrogen production in postmenopausal women","volume":"36","author":"Grodin","year":"1973","journal-title":"J Clin Endocrinol Metab"},{"key":"R18-9-20210128","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/0002-9378(71)90965-3","article-title":"Proliferative endometrial response to theca-granulosa cell tumors","volume":"111","author":"Gusberg","year":"1971","journal-title":"Am J Obstet Gynecol"},{"key":"R19-9-20210128","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1210\/jcem-38-3-476","article-title":"Plasma precursors of estrogen. II. Correlation of the extent of conversion of plasma androstenedione to estrone with age","volume":"38","author":"Hemsell","year":"1974","journal-title":"J Clin Endocrinol Metab"},{"key":"R20-9-20210128","first-page":"1531","article-title":"Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review","volume":"11","author":"Kaaks","year":"2002","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R21-9-20210128","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1097\/00000478-199808000-00012","article-title":"Reproducibility of the diagnosis of endometrial hyperplasia, atypical hyperplasia, and well-differentiated carcinoma","volume":"22","author":"Kendall","year":"1998","journal-title":"Am J Surg Pathol"},{"key":"R22-9-20210128","first-page":"271","article-title":"Expression of cyclooxyegenase-2 in endometrial adenocarcinoma","volume":"26","author":"Kilic","year":"2005","journal-title":"Eur J Gynaec Oncol"},{"key":"R23-9-20210128","first-page":"411","article-title":"Blaustein's pathology of the female genital tract. 4th ed","author":"Kurman","year":"1994a"},{"key":"R24-9-20210128","first-page":"441","article-title":"Blaustein's pathology of the female genital tract. 4th ed","author":"Kurman","year":"1994b"},{"key":"R25-9-20210128","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/1097-0142(19850715)56:2<403::AID-CNCR2820560233>3.0.CO;2-X","article-title":"The behavior of endometrial hyperplasia along term study of untreated hyperplasia in 170 patients","volume":"56","author":"Kurman","year":"1985","journal-title":"Cancer"},{"key":"R26-9-20210128","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1067\/mob.2003.284","article-title":"Expression of cyclooxygenase-2 in cervical, endometrial, and ovarian malignancies","volume":"188","author":"Landen","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"R27-9-20210128","doi-asserted-by":"crossref","first-page":"18563","DOI":"10.1074\/jbc.M010787200","article-title":"Overexpression of cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic mice","volume":"276","author":"Liu","year":"2001","journal-title":"J Biol Chem"},{"issue":"Suppl 5","key":"R28-9-20210128","first-page":"21","article-title":"Cox 2 inhibition in clinical cancer prevention","volume":"15","author":"Lynch","year":"2001","journal-title":"Oncology"},{"key":"R29-9-20210128","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/0002-9378(78)90287-9","article-title":"Effect of obesity on conversion of plasma androstenedione to estrone in postmenopausal women with and without endometrial cancer","volume":"130","author":"MacDonald","year":"1978","journal-title":"Am J Obstet Gynecol"},{"key":"R30-9-20210128","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1210\/jcem-49-6-905","article-title":"Origin of estrogen in normal men and in women with testicular feminization","volume":"49","author":"MacDonald","year":"1979","journal-title":"J Clin Endocrinol Metab"},{"key":"R31-9-20210128","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1093\/jnci\/92.11.924","article-title":"Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers","volume":"92","author":"Mutter","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"R32-9-20210128","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1093\/annonc\/mdi021","article-title":"Third generation aromatase inhibitors may prevent endometrial growth and reverse tamoxifen-induced uterine changes in postmenopausal breast cancer patients","volume":"16","author":"Morales","year":"2005","journal-title":"Ann Oncol"},{"key":"R33-9-20210128","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1067\/mjd.2001.117432","article-title":"Estrogen production and action","volume":"45","author":"Nelson","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"R34-9-20210128","first-page":"174","article-title":"Aromatase expression in endometriosis","volume":"81","author":"Noble","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"R35-9-20210128","first-page":"573","article-title":"Comparison of endometrial carcinoma coexisting with and without endometrial hyperplasia","volume":"21","author":"Ohkawara","year":"2000","journal-title":"Eur J Gynaecol Oncol"},{"key":"R36-9-20210128","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0960-0760(01)00187-X","article-title":"Signaling pathways regulating aromatase and cyclooxygenases in normal and malignant breast cells","volume":"80","author":"Richards","year":"2002","journal-title":"J Steroid Biochem Mol Biol"},{"key":"R37-9-20210128","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.ajog.2004.10.605","article-title":"Racial differences in the overexpression of epidermal growth factor type II receptor (HER2\/neu): a major prognostic indicator in uterine serous papillary cancer","volume":"192","author":"Santin","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"R38-9-20210128","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ygyno.2003.08.018","article-title":"Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases","volume":"91","author":"Slomovitz","year":"2003","journal-title":"Gynecol Oncol"},{"key":"R39-9-20210128","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1677\/jme.0.0310095","article-title":"Induction of cyclooxygenase-2 in human endometrial stromal cells by malignant endometrial epithelial cells: evidence for the involvement of extracellularly regulated kinases and CCAAT\/enhancer binding proteins","volume":"31","author":"Tamura","year":"2003","journal-title":"J Mol Endocrinol"},{"key":"R40-9-20210128","doi-asserted-by":"crossref","first-page":"26208","DOI":"10.1074\/jbc.M201347200","article-title":"Up-regulation of cyclooxygenase-2 expression and prostaglandin synthesis in endometrial stromal cells by malignant endometrial epithelial cells. A paracrine effect mediated by prostaglandin E2 and nuclear factor-kappa B","volume":"277","author":"Tamura","year":"2002","journal-title":"J Biol Chem"},{"key":"R41-9-20210128","first-page":"3935","article-title":"Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies","volume":"57","author":"Tashiro","year":"1997","journal-title":"Cancer Res"},{"key":"R42-9-20210128","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1001\/jama.1996.03530290040035","article-title":"Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The Postmenopausal Estrogen\/Progestin Interventions (PEPI) trial","volume":"275","year":"1996","journal-title":"JAMA"},{"key":"R43-9-20210128","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1080\/078538902321012379","article-title":"The expression of cyclooxygenase-1 and -2 in proliferative endometrium and endometrial adenocarcinoma","volume":"34","author":"Uotila","year":"2002","journal-title":"Ann Med"},{"key":"R45-9-20210128","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/cncr.21649","article-title":"Reproducibility of the diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study","volume":"106","author":"Zaino","year":"2006","journal-title":"Cancer"},{"key":"R46-9-20210128","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1210\/mend.13.2.0229","article-title":"Stimulation of aromatase P450 promoter (II) activity in endometriosis and its inhibition in endometrium are regulated by competitive binding of steroidogenic factor-1 and chicken ovalbumin upstream promoter transcription factor to the same cis-acting element","volume":"13","author":"Zeitoun","year":"1999","journal-title":"Mol Endocrinol"},{"key":"R47-9-20210128","doi-asserted-by":"crossref","first-page":"5739","DOI":"10.1210\/endo.137.12.8940410","article-title":"Estrogen biosynthesis proximal to a breast tumor is stimulated by PGE2 via cyclic AMP, leading to activation of promoter II of the CYP19 (aromatase) gene","volume":"137","author":"Zhao","year":"1996","journal-title":"Endocrinology"}],"container-title":["European Journal of Cancer Prevention"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00008469-200804000-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:44:19Z","timestamp":1786038259000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00008469-200804000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/cej.0b013e32811080ce","relation":{},"ISSN":["0959-8278"],"issn-type":[{"value":"0959-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2008,4]]}}}